Motivation for Exercise and Physical Activity Adherence
MOVE
Understanding Motivation for Exercise to Enhance Physical Activity Adherence in Adults With Obesity
2 other identifiers
observational
39
1 country
1
Brief Summary
The limited success of our current approaches to increase adoption and maintenance of physical activity in adults with overweight and obesity is a substantial barrier to effectively address the current obesity epidemic. This mentored F32 application addresses the significant public health issue of obesity and associated risk of major chronic diseases by using mixed methods research to optimize an innovative, theoretically based physical activity intervention designed to enhance motivation for exercise in adults with overweight and obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2021
CompletedFirst Submitted
Initial submission to the registry
June 15, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedJune 23, 2021
June 1, 2021
2.2 years
June 15, 2021
June 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acceptability
During a 90-minute semi-structured focus group, participants were asked about their satisfaction with major aspects of the MOVE physical activity support program including: 1) MOVE content and 2) delivery of MOVE content including meeting frequency and structure for both group-based and 1:1 meetings. Participants were also asked about their overall experience with the MOVE program, things that worked well, things that did not work well, and about the most important things they learned from the MOVE program.
weeks 21-30
Secondary Outcomes (6)
Motivation for Physical Activity
weeks 21-30
Motivation for Sedentary Behavior
weeks 21-30
Barriers to Physical Activity
weeks 21-30
Facilitators to Physical Activity
weeks 21-30
Perceptions of Physical Activity Messages
weeks 21-30
- +1 more secondary outcomes
Study Arms (3)
Cohort 2
This group of study participants started the 52-week parent randomized controlled trial (NCT03411356) on February 13, 2019.
Cohort 3
This group of study participants started the 52-week parent randomized controlled trial (NCT03411356) on November 5, 2019.
Cohort 4
This group of study participants started the 52-week parent randomized controlled trial (NCT03411356) on October 22, 2020.
Interventions
The MOVE physical activity support program is based on the Self-Determination Theory and targets autonomous motivation for physical activity by encouraging 1) choice in physical activity type (e.g. walking, household chores, yoga), 2) a meaningful, value-based rationale for engaging in physical activity, and 3) physical activity that is intrinsically enjoyable. MOVE was delivered during two, 60-75 minute group-based classes and one, 45 minute individualized 1:1 support session to enhance adherence to physical activity recommendations within a lifestyle weight loss program. The group-based classes included a combination of PowerPoint slides, participant handouts, and group-based discussions. All MOVE content was delivered by trained study staff.
Eligibility Criteria
Volunteers from the parent trial who are eligible and willing to participate were included in the focus groups. To achieve aim 1 of this proposal, participants randomized to cohorts 2-4 of the parent study who have completed at least 2 of the 3 MOVE components were invited to participate in a focus group.
You may qualify if:
- A current study participant randomized to the parent trial in cohorts 2-4 for COMIRB, Protocol #17-0369
- Completed at least 2 of 3 MOVE program components (attended ≥80% of either group-based class and/or attended the one-on-one support session).
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Danielle M Ostendorf, PhD
University of Colorado Anschutz Health and Wellness Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2021
First Posted
June 23, 2021
Study Start
February 13, 2019
Primary Completion
April 14, 2021
Study Completion
April 14, 2021
Last Updated
June 23, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share